Clinical Trials Logo

Clinical Trial Summary

Animal-assisted therapy (AAT) is a complementary intervention of therapy that has shown positive results in the treatment of various pathologies. This study assesses the viability of the implementation and the effectiveness of an AAT program in patients diagnosed with borderline personality disorder and substance abuse disorder. Our hypotheses are that participation in the TAA program will reduce negative symptoms, improve the quality of life of people with dual pathology, whose mental illness is schizophrenia, and increase adherence to treatment for people with dual pathology, whose mental disorder it's schizophrenia.


Clinical Trial Description

Animal assisted therapy (AAT) is a complementary intervention to therapy that presents positive results in the treatment of different pathologies. The study assesses the implementation and effectiveness of a TAA program in patients diagnosed with borderline personality disorder and substance abuse disorder. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05115266
Study type Interventional
Source Cardenal Herrera University
Contact
Status Not yet recruiting
Phase N/A
Start date April 30, 2022
Completion date April 30, 2025

See also
  Status Clinical Trial Phase
Completed NCT00583440 - 12-step Facilitation for the Dually Diagnosed Phase 1/Phase 2
Completed NCT00237822 - Increasing Treatment Adherence in Co-Occurring Psychiatric and Drug Use Disorders Phase 2
Not yet recruiting NCT04442776 - Dual Integrated Attention Program (DAIP) in People With Severe Dual Diagnosis N/A
Completed NCT05103865 - Animal-Assisted Therapy in the Residential Treatment of Schizophrenia and Addictions N/A
Active, not recruiting NCT01135420 - Dual Diagnosis Inpatients: Telephone Monitoring RCT to Improve Outcomes Phase 2